Cargando…
Patient perspectives on the British Columbia Biosimilars Initiative: a qualitative descriptive study
In May 2019, the Government of British Columbia (BC) announced the implementation of the Biosimilars Initiative, mandating the switch of biologic (originator) drugs to biosimilars for certain patient populations in the hopes of optimizing public resources. Through this qualitative study, we aimed to...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102664/ https://www.ncbi.nlm.nih.gov/pubmed/33961101 http://dx.doi.org/10.1007/s00296-021-04874-8 |